Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline antibody mouse model after a single bolus immunization
Ghosh, A. R.; Habib, R.; Mishra, N.; Roark, R. S.; Akauliya, M.; Albowaidey, A. A.; Allen, J. D.; Amereh, K.; Avillion, G.; Bottermann, M.; Liang, B.; Chaudhary, N.; Callaghan, S.; Dye, J.; Li, X.; Ellis-Pugh, J. R.; Chowdhury, R. R.; James, N. E.; Liu, X.; Maiorino, L.; Villavicencio, P. M.; Nedellec, R.; Oberoi, P.; Sowers, K. J.; Park, Y.; Prum, T.; Rodriguez, L.; Ssozi, M.; Torres, J.; Walsh, A. A.; Warner, J. E.; Weldon, S. R.; Xu, L.; Wiehe, K.; Crispin, M.; Ward, A. B.; Nair, U.; Hahn, B. H.; Burton, D. R.; Shapiro, L.; Kwong, P. D.; Irvine, D. J.; Andrabi, R.; Shaw, G. M.; Batista, F.
Show abstract
Current vaccine strategies to elicit broadly neutralizing antibodies (bnAbs) against HIV-1 generally propose complex, multi-boost immunization regimens. In rhesus macaques, SHIV infection has been observed to rapidly drive the development of some classes of bnAbs that share structural similarities with those in humans. Here, we generated a knockin mouse model with B cells bearing the unmutated common ancestor (UCA) of the V2 apex-targeted bnAb lineage, V033-a. A single immunization of mice with a germline-targeting native-like trimer was sufficient to recapitulate the ontogeny of the mature rhesus bnAb in knockin mice--including rare, disfavored somatic mutations--leading to the induction of antibodies that exhibited potent neutralization against both autologous and heterologous tier 2 viruses. A boost with Env escape mutant trimers further improved breadth and potency, and cryo-EM structure revealed the structural basis for heterologous neutralization breadth. Non-human primate and mouse models can thus combine with structure to serve as a platform for identifying and confirming immunogens that streamline HIV-vaccination regimens.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants 97%
- Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease 96%
- Live imaging of SARS-CoV-2 infection in mice reveals neutralizing antibodies require Fc function for optimal efficacy 96%
Similar papers in this journal
- Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus Macaques 98%
- Polyclonal epitope cartography reveals the temporal dynamics and diversity of human antibody responses to H5N1 vaccination 98%
- Mapping polyclonal antibody responses in non-human primates vaccinated with HIV Env trimer subunit vaccines 98%
Similar papers in this journal
- Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 prime-boost vaccination 97%
- Broadly neutralizing antibodies target the coronavirus fusion peptide 96%
- Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.